CSIMarket
 
Eli Lilly And Company  (LLY)
Other Ticker:  
 
 

Eli Lilly Growth Comparisons

Select each growth Category to receive further Information



LLY Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 28.1 % - - -
Q / Q Revenue Growth (Q4 MRQ) -1.53 % - - -
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 19.56 % -8.48 % - %
Seq. Revenue Growth (for 12 months ending Q4 TTM) 6.4 % -3.63 % - 0.45 %
Revenue 5 Year Average Growth 6.8 % 5.92 % 6.21 % 7.95 %


LLY's Growth Comparisons in IV. Quarter 2023






Top-line fell by -1.53% from the third quarter. Average annual sales growth for Eli Lilly is 6.8%, while S & P 500's average yearly sales increase is 7.95%, including only Businesses with the forth quarter 2023 financial results.


Growth Rates of LLY's Income in the forth quarter 2023


LLY Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) 74.93 % - - -
Seq. Operating Income Change (Q4 MRQ) -6.22 % - - -
Y / Y Operating Income Growth (Q4 TTM) 43.92 % -35.5 % -34.14 % -2.56 %
Seq. Operating Income Growth (Q4 TTM) 15.49 % -16.92 % -10.93 % 0.17 %
Operating Income 5 Year Avg. Change 22.48 % 5.43 % 0.28 % 8.58 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) 13.01 % -25.3 % -6.31 % 11.92 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) - 12.19 % 54.57 % -12 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) -16.08 % -28.57 % -25.6 % 1.27 %
Seq. Income from Cont. Ops. Change (Q4 TTM) 5.05 % 10.38 % 14.13 % 3.39 %
Income from Cont. Ops. 5 Year Avg. Change 10.15 % 2.34 % -2.11 % 7.98 %

LLY Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) 13.01 % -24.71 % -5.31 % 6.18 %
Q / Q Net Income Growth (Q4 MRQ) - -60.27 % -40.1 % -20.46 %
Y / Y Net Income Change (Q4 TTM) -16.08 % -5.27 % -4.16 % 2.92 %
Seq. Net Income Change (Q4 TTM) 5.05 % 7.77 % 10.9 % 2.05 %
Net Income 5 Year Avg. Growth 10.15 % 7.94 % 2.37 % 8.29 %

LLY's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) 13.15 % 5.29 % -6.31 % 11.92 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) - 22.36 % 54.57 % -12 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) -15.99 % - - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) 5.1 % - - 0 %
EPS from Cont. Ops. 5 Year Avg. Growth 13.14 % -3.2 % -2.11 % 7.98 %



LLY EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) 12.87 % 6.12 % -5.31 % 7.98 %
Q / Q EPS Net Growth (Q4 MRQ) - -56.66 % -40.1 % -20.46 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 59631.5 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) 5 % - - 0.03 %
EPS Net 5 Year Avg. Change 13.13 % 7.94 % 2.37 % 8.29 %



Eli Lilly's 12.87% year on year bottom-line increase in the forth quarter to $2.42 , marks slow-down from Eli Lilly's growth trends, but compares favorably to the 6.12% growth in the Major Pharmaceutical Preparations industry, and -5.31% decrease in the Healthcare sector. Despite modest earnings per share rises in the Healthcare sector and Major Pharmaceutical Preparations industry, Eli Lilly And Company reported above average market earnings per share growth.

the bottom-line fell by -1.53% from the third quarter. Average annual income per share growth for Eli Lilly is 13.13%, while S & P 500's average yearly income per share increase is 8.29%, including only Businesses with the forth quarter 2023 earnings.

LLY Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - -22.55 % -16.82 % -6.49 %
Seq. Free Cash Flow Change (Q4 MRQ) - -24.96 % -14.01 % 1.18 %
Y / Y Free Cash Flow Change (Q4 TTM) -40.15 % -15.9 % -12.51 % -0.6 %
Seq. Free Cash Flow Change (Q4 TTM) -30.85 % -3.79 % -3.31 % 4.92 %
Free Cash Flow 5 Year Avg. Change -11.1 % 13.55 % 9.74 % 7.92 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - 114.55 % - -
Seq. Net Cash Flow Change (Q4 MRQ) - 258.84 % - -
Y / Y Net Cash Flow Change (Q4 TTM) - - - -
Seq. Net Cash Flow Change (Q4 TTM) - 87.03 % -42.66 % 1000.57 %
Net Cash Flow 5 Year Avg. Change -12.46 % -1.45 % 3.69 % 27.81 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) 113.82 % -0.99 % -2.99 % -16.88 %
Seq. Capital Expenditures Change (Q4 MRQ) 10.34 % 8.85 % 11.65 % -0.91 %
Y / Y Capital Expenditures Change (Q4 TTM) 85.92 % 15.36 % 10.01 % 15.58 %
Seq. Capital Expenditures Change (Q4 TTM) 19.8 % 5.29 % 3.18 % 35.73 %
Capital Expenditures 5 Year Avg. Change 23.28 % 10.1 % 6.84 % 6.98 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com